Azithromycin Attenuates Bleomycin-Induced Pulmonary Fibrosis Partly by Inhibiting the Expression of LOX and LOXL-2

• Hauptverfasser: Xiang Tong (Verfasst von), Shijie Zhang (Verfasst von), Dongguang Wang (Verfasst von), Li Zhang (Verfasst von), Jizheng Huang (Verfasst von), Tianli Zhang (Verfasst von), Hong Fan (Verfasst von)
• Format: Buch
• Veröffentlicht: Frontiers Media S.A., 2021-11-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Pulmonary fibrosis (PF) is a chronic and progressive process of tissue repair. Azithromycin (AZM) may be beneficial for the treatment of PF because AZM has anti-inflammatory and immune regulatory roles and inhibits remodeling, but the mechanism is not entirely clear. In this study, we established a...